CYP2C83 increases risk of neuropathy in breast cancer patients treated with paclitaxel von Hertz, D.L., Roy, S., Motsinger-Reif, A.A., Drobish, A., Clark, L.S., McLeod, H.L., Carey, L.A., Dees, E.C.

Volltext

Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer von Nyrop, K. A., Damone, E. M., Deal, A. M., Wheeler, S. B., Charlot, M., Reeve, B. B., Basch, E., Shachar, S. S., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., Reinbolt, R. E., Speca, J. C., Wood, W. A., Muss, H. B.

Volltext

Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer von Nyrop, K. A., Deal, A. M., Choi, S. K., Wagoner, C. W., Lee, J. T., Wood, A., Anders, C., Carey, L. A., Dees, E. C., Jolly, T. A., Reeder-Hayes, K. E., Muss, H. B.

Volltext

The product of the H19 gene may function as an RNA von BRANNAN, C. I, DEES, E. C, INGRAM, R. S, TILGHMAN, S. M

Volltext

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer von Dees, E. Claire, O'reilly, Seamus, Goodman, Steven N., Sartorius, Susan, Levine, Marshall A., Jones, Richard J., Grochow, Louise B., Donehower, Ross C., Fetting, John H.

Volltext

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM) von Moschos, S.J., Eroglu, Z., Khushalani, N.I., Kendra, K.L., Ansstas, G., In, G.K., Wang, P., Liu, G., Collichio, F.A., Arrowood, C.C., Reed, J.E., Garrett-Mead, N., Thomas, N.E., Ollila, D.W., Ivy, S.P., Ivanova, A., Dees, E.C., Abbruzzese, J.L.

Volltext

Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer von Nyrop, K. A., Deal, A. M., Choi, S. K., Wagoner, C. W., Lee, J. T., Wood, W. A., Anders, C., Carey, L. A., Dees, E. C., Jolly, T. A., Reeder-Hayes, K. E., Muss, H. B.

Volltext

The Proteasome as a Target for Cancer Therapy von VOORHEES, Peter M, DEES, E. Claire, O'NEIL, Bert, ORLOWSKI, Robert Z

Volltext

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter M, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W

Volltext

Implications for Treatment of Variations in Length of the First Metacarpal in Different Types of Triphalangeal Thumbs von Zuidam, J. M., Dees, E. E. C., Selles, R. W., Hovius, S. E. R.

Volltext

The Effect of the Epiphyseal Growth Plate on the Length of the First Metacarpal in Triphalangeal Thumb von Zuidam, J. Michiel, Dees, Esther E.C., Lequin, Maarten H., Hovius, Steven E.R.

Volltext

Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study von Partridge, Ann, Adloff, Kristie, Blood, Emily, Dees, E. Claire, Kaelin, Carolyn, Golshan, Mehra, Ligibel, Jennifer, de Moor, Janet S., Weeks, Jane, Emmons, Karen, Winer, Eric

Volltext

Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor von Kizilbash, S.H., El-Khoueiry, A., Lerner, R.E., Ma, P.C., Almubarak, M., Mody, K., Burkard, M.E., Guarino, M., Jenab-Wolcott, J., Sankar, N., Choy, G., Espiritu, L., Zhang, X., Luria, A., Benedetti, F., Dees, E.C.

Volltext

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer von DEES, E. Claire, MCKINNON, Karen P, CAREY, Lisa A, BRECHER, Mark E, GRAHAM, Mark, EARP, H. Shelton, SERODY, Jonathan S, KUHNS, Jennifer J, CHWASTIAK, Kathryn A, SPARKS, Scotty, MYERS, Mary, COLLINS, Edward J, FRELINGER, Jeffrey A, VAN DEVENTER, Henrik, COLLICHIO, Frances

Volltext

Role of cytochrome P450 phenotyping in cancer treatment von Dees, E Claire, Watkins, Paul B

Volltext

340PDose-escalation study of G1T48, an oral selective estrogen receptor degrader (SERD), in postmenopausal women with ER+/HER2- locally advanced or metastatic breast cancer (ABC) von Dees, E C, Aftimos, P G, Menke-van der, C W, van Oordt, Houven, De Vries, E G E, Neven, P, Pegram, M D, Iqbal, R, Boers, J, Xiao, J, Sipes, C, Li, C, Sorrentino, J A, Malik, R, Beelen, A P

Volltext

LBA18Clinical outcomes by chemotherapy regimen in patients with RS 26-100 in TAILORx von Sparano, J, Gray, R J, Makower, D, Albain, K, Saphner, T J, Badve, S, Wagner, L, Mihalcioiu, C, Desbiens, C, Hayes, D F, Dees, E C, Geyer, C, Olson, J, Wood, W C, Lively, T, Paik, S, Ellis, M, Abrams, J S, Sledge, G W

Volltext

A dose-escalation study of weekly intravenous CRLX301 in patients with advanced solid tumor malignancies von Wang, H., Markman, B., de Souza, P., Dees, E.C., Gangadhar, T.C., Piha-Paul, S.A., Zamboni, W.C., Murphy, C., Senderowicz, A.

Volltext

1268PNCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM) von Moschos, S J, Eroglu, Z, Khushalani, N I, Kendra, K L, Ansstas, G, In, G K, Wang, P, Liu, G, Collichio, F A, Arrowood, C C, Reed, J E, Garrett-Mead, N, Thomas, N E, Ollila, D W, Ivy, S P, Ivanova, A, Dees, E C, Abbruzzese, J L

Volltext

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily... von Burris, 3rd, Howard A, Hurwitz, Herbert I, Dees, E Claire, Dowlati, Afshin, Blackwell, Kimberly L, O'Neil, Bert, Marcom, Paul K, Ellis, Matthew J, Overmoyer, Beth, Jones, Suzanne F, Harris, Jennifer L, Smith, Deborah A, Koch, Kevin M, Stead, Andrew, Mangum, Steve, Spector, Neil L

Volltext